Patents
Upon successful funding, canZero Inc. owns exclusive licenses in the filed of oncology of the US patents# and patent applications related to the Self-Assembling Protein Nanoparticles (SAPNs). These are:
-
US8575110-B2 - Peptidic nanoparticles as drug delivery and antigen display systems
-
US8546337-B2 - Self-assembling peptide nanoparticles useful as vaccines
-
US10245318-B2 - Flagellin-containing protein nanoparticles as a vaccine platform
-
US20240075120-A1 - Self-assembling protein nanoparticles encapsulating immunostimulatory nucleic acids
-
US20200017554-A1 - Self-assembling protein nanoparticles with built-in six-helix bundle protein
-
US63/873,012 - Self-assembling protein nanoparticles comprising histidines
#Also the most important countries world-wide are covered by the patents.
